Viewing nowCombinationExmet 50/1000 mg Tablets
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202204569 · Approved 2022.12.21 · Insurance code 671707240
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps control blood glucose levels in patients with type 2 diabetes by the combined action of sitagliptin and metformin. It assists in effectively lowering and managing blood glucose when used in conjunction with dietary and exercise therapies. Therefore, this medication is used to improve blood glucose control in patients with type 2 diabetes.
For antidiabetic therapy, the dose of this product should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. This product is generally taken twice daily with meals. To reduce gastrointestinal adverse reactions caused by metformin, increase the dose gradually. The initial dose of this product should be determined according to the patient's current treatment regimen. 1. Patients not currently receiving metformin: For patients with no prior experience with diabetes medication who cannot achieve adequate glycemic control with monotherapy, or for patients who cannot achieve adequate glycemic control with sitagliptin monotherapy, the initial dose is 1 tablet of this product 50/500 mg twice daily; this may be increased to 1 tablet of this product 50/1000 mg twice daily. Patients with renal impairment who are receiving a reduced dose of sitagliptin must not be switched to this product (see Precautions for Use, 2. Patients Who Must Not Use This Product). 2. Patients receiving metformin: - For patients who cannot achieve adequate glycemic control with metformin monotherapy, the recommended initial dose of this product is a total daily dose of sitagliptin 50 mg twice daily (total daily dose 100 mg) and the patient's current dose of metformin. - Patients switching from combination therapy with sitagliptin and metformin to this product may start at their current doses of sitagliptin and metformin. 3. Patients who cannot achieve adequate glycemic control with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial dose of this product is sitagliptin 50 mg twice daily (total daily dose 100 mg); the initial dose of metformin should be determined based on the patient's blood glucose level and current dose. To reduce gastrointestinal adverse reactions caused by metformin, increase the dose gradually. When used with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). No studies have been conducted to evaluate the safety and efficacy of switching patients previously treated with other oral antihyperglycemic agents to this product. Any change in the treatment regimen for type 2 diabetes may affect glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. Patients with renal impairment This product may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and < 60 mL/min/1.73m2), who do not have other symptoms that may increase the risk of lactic acidosis, with the following dose adjustment. Treatment with this product should not be initiated, since the starting dose of metformin is 500 mg or 850 mg once daily. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, this product must be discontinued immediately. Patients with hepatic impairment This product must not be administered to patients with hepatic impairment because it contains metformin (see Precautions for Use, 2. Patients Who Must Not Use This Product).
This medication contains two components, each with its precautions. First, one component of this medication can rarely cause severe allergic reactions, so if symptoms such as skin rash or difficulty breathing occur after taking the medication, it should be stopped immediately and consultation with a doctor is necessary. Additionally, this medication carries the risk of pancreatitis, which is inflammation of the pancreas, so it is important to quickly inform medical personnel if symptoms such as abdominal pain, nausea, or vomiting arise. The other component may pose risks to patients with reduced kidney function, thus kidney function tests are needed, and it should not be taken if kidney function is significantly compromised. This medication should not be administered to patients with compromised liver function or those suffering from acute illnesses such as severe infections, dehydration, or acute myocardial infarction. Women who are pregnant or may become pregnant, as well as breastfeeding women, should also refrain from taking this medication. While taking this medication, symptoms of hypoglycemia may occur, so it is particularly important to frequently check blood glucose levels and closely observe for symptoms of hypoglycemia, especially when combined with other hypoglycemic agents. Moreover, this medication can be dangerous when taken with alcohol, so it is advisable to avoid drinking. A certain period of discontinuation of this medication is necessary before and after surgery, and it should only be resumed after kidney function has recovered post-surgery. Finally, regular meals, exercise, and consistent monitoring of blood glucose and kidney function are necessary to manage health status properly while taking this medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air and moisture infiltration. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. This helps to preserve the medication's efficacy over time.
Dark red oval film-coated tablet
56 tablets/box [14 tablets/PTP×4], 30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.